San Diego, CA (PRWEB) November 01, 2016
Book-ended by molecular analyses and live animal studies, cell-based assays are an indispensable tool for both basic and applied biological research. However, a long-standing challenge with most cell-based assays is that they only evaluate a single time point for just one molecular target. In contrast, the xCELLigence Real-Time Cell Analyzers produced by ACEA Biosciences enable cell health and behavior to be monitored continuously in a non-invasive manner. This technology maximizes the physiological relevance of data obtained in a wide variety of assays that include, but are not limited to, immune cell-mediated killing of cancer cells, cancer cell invasion/migration, predictive toxicology and cardiotoxicity, drug discovery, and immune cell activation.
As part of its award announcement, CV Magazine interviewed Dr. Xiaobo Wang, ACEA’s Chief Technology Officer. Dr. Wang explained that from its inception a major goal of ACEA has been to “transform cell-based assays by improving the accuracy, reliability, and scope of cell measurements,” so that dynamic responses to small molecules, biomolecules, or other cells in culture can be evaluated.
With nearly 1,800 xCELLigence instruments in use globally, leading to >1,250 publications in dozens of research fields, this technology has begun to represent the new standard for cell-based assays.
For Dr. Wang’s complete interview on page 45 of October’s issue of CV Magazine, click here.
About ACEA Biosciences
Founded in 2002, ACEA Biosciences is a pioneer in the development and commercialization of high performance, cutting edge cell analysis platforms for life science research. ACEA’s xCELLigence® impedance-based, label-free, real-time cell analysis instruments and NovoCyte® flow cytometers are used in pre-clinical drug discovery and development, toxicology, safety pharmacology, and basic academic research.
For more information, click here.
For further information please contact:
ACEA Biosciences, Inc.
Dr. Jeff Xue
Phone: 1-858-724-0928, x3075